Bristol Myers Squibb (BMY)

EBITDA Margin

34.19%

TTM · Period ending:

BMY logo

BMY EBITDA Margin

Latest reported34.19%
BMY TTM EBITDA Margin (19.41% → 34.19%)
High-resolution chart · PNG

BMY ebitda margin history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Bristol Myers Squibb EBITDA Margin — Trailing twelve months (TTM)
Period endingEBITDA Margin
37.1086%
36.1763%
34.745%
33.3854%
31.6065%
31.1664%
31.4262%
31.027%
31.8736%
31.789%
31.4264%
30.9305%
30.6389%
30.4584%
30.112%
29.9537%
29.7742%
29.7001%
29.6847%
30.1468%
29.8624%
29.6993%
29.5126%
28.679%
29.0577%
29.3952%
29.6228%
24.6568%
24.316%
24.0623%
23.7557%
21.7134%
21.095%
20.5697%
20.2133%
26.3351%
26.8381%
27.2419%
26.9917%
26.5286%
26.185%
26.0471%
25.5631%
-36.7493%
-21.8562%
-5.5958%
11.7858%
24.3508%
23.2908%
22.0308%
20.6824%
26.6454%
23.8339%
21.7648%
19.4099%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.